Srovnání pegylovaného lipozomálního doxorubicinu a karboplatiny s paklitaxelem a karboplatinou v lécbe pacientek s pozdním relapsem platina-senzitivního karcinomu ovaria
[Comparison of pegylated liposomal doxorubicin and carboplatin with paclitaxel and carboplatin in the treatment of patients with late recurrence of platin-sensitive ovarian carcinoma]
Klinicka onkologie.
2011 ;
24 (6) :
475-6.
Language Czech Country Czech Republic Media print
Document type Comparative Study, Journal Article
Persistent link
https://www.medvik.cz/link/pmid22268244
PubMed
22268244
- MeSH
- Doxorubicin administration & dosage adverse effects analogs & derivatives MeSH
- Carboplatin administration & dosage adverse effects MeSH
- Humans MeSH
- Neoplasm Recurrence, Local drug therapy MeSH
- Ovarian Neoplasms drug therapy MeSH
- Paclitaxel administration & dosage MeSH
- Polyethylene Glycols administration & dosage adverse effects MeSH
- Antineoplastic Combined Chemotherapy Protocols adverse effects therapeutic use MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Doxorubicin MeSH
- Carboplatin MeSH
- liposomal doxorubicin MeSH Browser
- Paclitaxel MeSH
- Polyethylene Glycols MeSH
